Proteína hidrolisada de aves e suínos em dietas para alevinos (tilápia do Nilo): desempenho produtivo e sobrevivência
Ano de defesa: | 2020 |
---|---|
Autor(a) principal: | |
Orientador(a): | |
Banca de defesa: | , , |
Tipo de documento: | Dissertação |
Tipo de acesso: | Acesso aberto |
Idioma: | por |
Instituição de defesa: |
Universidade Estadual do Oeste do Paraná
Toledo |
Programa de Pós-Graduação: |
Programa de Pós-Graduação em Recursos Pesqueiros e Engenharia de Pesca
|
Departamento: |
Centro de Engenharias e Ciências Exatas
|
País: |
Brasil
|
Palavras-chave em Português: | |
Palavras-chave em Inglês: | |
Área do conhecimento CNPq: | |
Link de acesso: | https://tede.unioeste.br/handle/tede/5827 |
Resumo: | The present study aimed to evaluate the effects of increasing levels of inclusion in the diet of protein hydrolyzate composed of co-products of poultry and swine (giblets and liver) on the growth and stress resistance of Nile tilapia fry. For this purpose, 360 tilapia fingerlings with an average weight of 1.10 ± 0.07 g were used, randomly distributed in 24 polyethylene boxes (15 fish per box) with a capacity of 250 L, constituting six treatments with four replicates. The isoproteic and isoenergetic rations supplied until satiety five times a day, for 45 days and were formulated to contain 0.0; 0.3; 0.6; 0.9; 1.2 and 1.5% inclusion of hydrolyzed chicken protein (PHF) and hydrolyzed porcine liver protein (PHFS). At the end of the experimental period, the number of fish in each aquarium was counted and the weight and length of all individuals were measured to assess the influence of the hydrolyzate on zootechnical performance, where the parameters evaluated were the final weight, standard length final, specific growth rate, protein efficiency rate, condition factor and survival. The best hydrolyzate inclusion value obtained was 0.311% for final weight, 0.187% for final standard length, 0.205% for specific growth rate and 0.321% for protein efficiency rate, so as not to have influenced the condition factor and survival when compared to the control treatment, absent from the test ingredient. |